Pituitary apoplexy of a giant prolactinoma during pregnancy. (2nd September 2021)

• Record Type: Journal Article
• Authors: Khaldi, Safa; Saad, Ghada; Elfekih, Hamza; Ben Abdelkrim, Asma; Ach, Taieb; Kacem, Maha; Chaieb, Molka; Maaroufi, Amel; Hasni, Yosra; Ach, Koussay
• Is Part Of: Gynecological endocrinology. Volume 37:Number 9(2021)
• Page Start: 863
• Page End: 866
• Publication Date: 2021-09-02
• Subjects: Giant prolactinoma -- pregnancy -- pituitary apoplexy; Endocrine gynecology -- Periodicals; Generative organs, Female -- Diseases -- Periodicals; 618.1
• DOI: 10.1080/09513590.2021.1938527
• Languages: English
• ISSNs: 0951-3590

Abstract

Abstract: Aims and methods: Prolactinomas are a common cause of sexual dysfunction and infertility. We aimed, through this case report, to illustrate the difficulties of management of women with giant prolactinoma, especially in cases of desire of pregnancy. Results: A 30-year-old woman was referred to our department for secondary amenorrhea. Investigations showed a prolactin level of 5168 ng/mL and giant pituitary adenoma of 4 cm in diameter. Cytoreductive surgery was performed after failure to normalize prolactin levels during three years with medical treatment by cabergoline. After seven months, menstrual cycles have resumed, and after 13 months, the patient became pregnant. At 22nd week of gestation, she was admitted in our hospital for pituitary apoplexy. Medical treatment with bromocriptine was chosen. The vaginal premature delivery at 28 weeks gave birth to twins weighing 1 Kg each who died on the 7th day of life. Conclusion: This is a relevant clinical case that illustrates the efficacy of cytoreductive surgery in case of insufficient response to dopamine agonists to restore gonadal function. The possibility of a pregnancy should be considered in these patients since it can be associated with high maternal and fetal risks.